Home » FDA: IRB Corrects Consent Issues but Other Problems Remain
FDA: IRB Corrects Consent Issues but Other Problems Remain
January 20, 2010
Although an IRB has rectified FDA concerns regarding a lack of required information in consent forms, the board needs to specify how it plans to ensure
staff assesses studies and risks, an FDA warning letter says.